Oculis to Spotlight Transformative Late-Stage Pipeline at Eyecelerator and AAO 2025

ZUG, Switzerland, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on developing innovations for ophthalmic and neuro-ophthalmic diseases with significant unmet medical needs, today announced that Oculis’ innovative late-stage pipeline will be highlighted at Eyecelerator and at the American Academy of Ophthalmology (AAO) Annual Meeting.

At Eyecelerator, Riad Sherif, MD, Oculis’ Chief Executive Officer, will provide an update on the Company’s innovative late-stage pipeline. Featured updates will include the acceleration of Privosegtor into registrational trials for acute optic neuritis and non-arteritic anterior ischemic optic neuropathy following a positive meeting with the U.S. Food and Drug Administration (FDA); an update on the Phase 3 DIAMOND program with OCS-01 eye drops for diabetic macular edema with expected topline readouts in Q2 2026; and an update on the upcoming PREDICT-1 registrational trial with a genotype-based approach to investigate Licaminlimab in dry eye disease, anticipated to start in Q4 2025.

Surrounding AAO, Oculis will actively participate and support multiple events including Innovate Retina, the Inaugural Meeting of the Society for Artificial Intelligence in Vision and Ophthalmology (SAIVO) and the COPhy Satellite Symposium. At Innovate Retina, Arshad M. Khanani, MD, MS, FASRS, Chair of Oculis’ Retina Scientific Advisory Board and Board Member of Oculis, will join a panel session to discuss the emerging role of eye drops such as OCS-01 in the future treatment paradigms for diabetic macular edema.

Events details are as follows:

Eyecelerator @ AAO 2025:
Format: Corporate presentation
Session: Presenting Company Showcases
Presenter: Riad Sherif, MD, Chief Executive Officer
Presentation date and time: Thursday, October 16, 2025; 1:15 PM ET
Location: Orange County Convention Center, Orlando, FL

Innovate Retina:

Format: Panel discussion
Session: Session #4 - Can Eye drops Replace Intravitreal Injections?
Presenter: Arshad M. Khanani, MD, MA, FASRS
Presentation date and time: Thursday, October 16, 2025; 5:25 PM ET
Location: Hilton, Orlando, FL

SAIVO:

Event date and time: Thursday, October 17, 2025; 6:00 PM ET
Location: Hotel Landy, Orlando, FL

COPhy Satellite Symposium:

Event date and time: Thursday, October 17, 2025; 6:30 PM ET
Location: Hyatt Regency, Orlando, FL

AAO Annual Meeting

Event dates: October 18-20, 2025